Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AEZS-108 in Advanced Ovarian and Endometrial Cancer
NCT00569257Phase 2Completed
- Sponsor
- COSCIENS Biopharma Inc.
- Start
- Dec 2007
- Primary completion
- Jul 2011
- Modality
- Small Molecules, Peptide-Drug Conjugates
- Countries
- 2
01
Overview
A Phase 2 trial of zoptarelin doxorubicin in ovarian cancer, endometrial cancer (EC), sponsored by COSCIENS Biopharma Inc.. Started Dec 2007; status: completed.
02
Drugs
zoptarelin doxorubicin
03
Conditions
ovarian cancerendometrial cancer (EC)
Beyond the preview
Go deeper on NCT00569257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00569257.